Redeye comments on Nitro Games Q4 2023 report, which came in line with preliminary figures.
Redeye adjusts its estimates and fair value range following Genovis’ year-end report, which came in ...
Seemingly leaving the trough behind '24e-'25e sales up 2% '24e EV/EBITDA of 5x No surprises - repor...
Redeye updates on Embracer following its Q3-results which was close to our expectations, albeit with...
Redeye argues that the EBIT miss does not bring any concern to the longer-term profitability (or cas...
Redeye is encouraged by Railcare’s new and rather aggressive financial targets of SEK1 billion in sa...
Redeye provides an update in relation to Enzymatica’s Q4 2023 report.
In Q4, ESL Shipping reported net sales and EBIT above consensus (LSEG), while Telko and Leipurin seg...
Redeye takes a neutral view on Fortnox as the stock is trading slightly above our Base Case despite ...
Redeye takes a neutral view towards Efecte following the Q4 report, as the stock trades in line with...
Redeye has updated its estimates for Carasent following the Q4 2023 report, which showed slightly st...
Redeye states that the report aligned with preliminary figures and showed net sales in line with est...
Redeye in this note provides some reflections on Acconeer's year-end report and the subsequent CEO l...
Q4 sales SEK 87m, up 6% y-o-y, EBIT SEK -0.8m (-8.8m) Smart Properties seeing improvements in Q1 vs.
Overall Impact Coatings is reporting solid Q4 numbers, reaching a positive EBITDA for the quarter.
Redeye is encouraged by the news this morning that Lifeclean has signed another potentially signific...
Partnerersättning i Q4 Bolagets licenspartner Tango Therapeutics har avancerat sitt projekt TNG348 i...
Bra tillväxt och goda marginaler y/y Arise rapporterade ett starkt resultat för Q4’23 med en försälj...
Utmanande år för Waystream 2023 blev ett utmanande år för Waystream.
Ökad vinst trots fortsatt motvind i fordonssegmentet Omsättningen under det fjärde kvartalet minskad...
